MDMA-assisted therapy shows promise for trauma and depression in mental illness

This systematic review and meta-analysis looked at MDMA-assisted therapy for people with mental illness. The study included 295 participants who received the intervention or control treatments. Researchers found a significant moderate-to-large reduction in overall psychopathology compared to controls. Effects on trauma were strong, while effects on depression were smaller and not statistically significant. The therapy showed larger effects when compared to inert placebos than when compared to active controls. Safety data were not reported in the included studies, and the quality of harm reporting was described as mediocre. The review notes that small sample sizes and confounding factors limit the certainty of these findings. While the results suggest potential benefits, larger and more transparent clinical trials are required before this approach can be widely recommended. Readers should understand that this evidence is early and observational in nature. More research is needed to confirm these results and ensure patient safety.